Encompass Health Co. (NYSE:EHC) Shares Sold by American Century Companies Inc.

American Century Companies Inc. trimmed its position in Encompass Health Co. (NYSE:EHC) by 3.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 404,918 shares of the company’s stock after selling 12,734 shares during the period. American Century Companies Inc. owned approximately 0.40% of Encompass Health worth $37,395,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in EHC. MassMutual Private Wealth & Trust FSB boosted its stake in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after purchasing an additional 177 shares in the last quarter. Finally, Signaturefd LLC lifted its stake in Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after purchasing an additional 125 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on EHC. Barclays increased their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. KeyCorp lifted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Up 0.8 %

Shares of Encompass Health stock opened at $101.19 on Friday. The stock has a 50-day simple moving average of $98.55 and a 200-day simple moving average of $97.31. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The firm has a market cap of $10.19 billion, a price-to-earnings ratio of 22.69, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.